SB 280 creates a statutory framework for proving and recovering damages for medical services or treatment in Utah civil cases (excluding health care malpractice). It defines key terms, caps recoverable medical damages to amounts actually paid, amounts necessary to pay unpaid charges, and amounts necessary for future care, and restricts admissible proof to those amounts.
The bill also sets evidentiary rules for insured and uninsured claimants, treats letters of protection and sold receivables specially, and requires plaintiffs who received care under a letter of protection to make detailed disclosures — including the sale price if a factoring company bought the right to collect. The change shifts how plaintiffs, defendants, providers, insurers, and third‑party purchasers value and litigate medical damages.
At a Glance
What It Does
The bill limits a plaintiff's recovery for necessary medical services to the actual amounts paid by or on behalf of the plaintiff, unpaid amounts due, and amounts necessary to pay future care. It narrows admissible proof to amounts actually paid or necessary, including insurer obligations and patient liability under a health plan, and adds disclosure duties when treatment was under a letter of protection.
Who It Affects
Directly affects plaintiffs in personal injury and wrongful death suits, defendants and their insurers, health care providers who bill for services, health plans (public and private), and factoring companies that buy medical receivables. It does not apply to malpractice claims against health care providers under Utah's malpractice act.
Why It Matters
The bill changes the baseline for calculating medical damages away from billed charges toward real payments and obligations, likely reducing headline damage claims and shifting litigation to proofs of negotiated rates, plan obligations, and factoring transactions. Compliance teams, plaintiff lawyers, and hospitals will need new documentation practices.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB 280 creates a single statutory rule for valuing medical damages in civil actions (other than health care malpractice). Instead of allowing recovery based on a provider's billed charges or disputed “reasonable value” estimates untethered to payment, the statute ties recovery to economic reality: what was actually paid by or on behalf of the plaintiff, what is actually owed to providers at trial, and what will be necessary to pay for future medical care.
That recalibrates the metric courts must use when instructing juries or admitting evidence on medical damages.
The bill defines commonly litigated concepts — health plan, letter of protection, factoring company, and medical service or treatment — to make clear which payment sources and business arrangements must be considered. For insured claimants, parties may introduce evidence of the amount the plan is obligated to pay and the amount the plaintiff remains liable to the provider; for uninsured or LOP cases, the statute permits evidence of what a plan would have paid if submitted.
The statute also explicitly allows admission of the amount a third party paid to acquire the right to collect under a letter of protection, which brings factoring transactions into the damages calculus.On procedure, SB 280 narrows admissible damage proof to items tied to actual payment obligations or reasonable billed amounts for future care. That both limits the use of inflated billed charges as a proxy for value and preserves the ability to prove what will be needed going forward.
The reporting side requires plaintiffs who received care under a letter of protection to produce the LOP, itemized and coded charges, information on any sale of the receivable (including purchaser name and purchase price/discount), and the plaintiff's coverage status and plan identity if applicable. Those disclosures are intended to let defense counsel and the court verify what was paid or will be paid and to reduce surprise at trial.Taken together, these changes push litigation toward documentation and contract-level proofs: plan contracts and allowed payment rates, proof of discounts or sales to factoring companies, and clear itemized bills.
That will change pretrial discovery priorities and create new arguments over which payment obligations are “necessary” for future care, how to treat negotiated discounts, and whether transferred receivables reflect actual provider losses or market pricing for risk and delay.
The Five Things You Need to Know
The bill enacts Utah Code §78B-5-621 establishing the new rules for recovery of medical damages in civil actions (excluding health care malpractice).
A plaintiff's recovery for necessary medical services cannot exceed amounts actually paid by or on behalf of the plaintiff, unpaid amounts due at trial, and amounts necessary to pay for future care.
Admissible evidence is limited to actual payments or necessary payment obligations, including insurer obligations, patient liabilities under a health plan, and amounts a third party paid to acquire a right to payment under a letter of protection.
When medical care was provided under a letter of protection, the plaintiff must disclose the LOP, itemized/coded charges, the identity of any factoring purchaser and the purchase price (including discounts), and the plaintiff's health plan status and identity if covered.
The statute explicitly treats both insured and uninsured scenarios: it permits evidence of what a health plan is obligated to pay, what the patient owes, and what the plan would have paid if charges were submitted.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Definitions for payment and collection terms
This subsection defines core terms — 'factoring company,' 'health care provider,' 'health plan,' 'letter of protection,' and 'medical service or treatment.' Practically, the definitions sweep broadly: health plan includes private insurance, employer plans, workers' comp, Medicare/Medicaid, and other government programs; medical service includes not only procedures but equipment, drugs, and items provided at a provider's direction. That breadth ensures the statute covers most payment sources and types of care encountered in civil litigation.
Scope: civil actions except health care malpractice
The statute applies to civil injury and wrongful death actions but excludes malpractice suits under Utah's Health Care Malpractice Act. This carve-out keeps the malpractice statutory regime intact while changing damages valuation in other tort cases, so hospitals, providers, and malpractice carriers should treat malpractice filings differently from standard tort claims.
Caps recoverable medical damages to paid, owed, and future necessary amounts
Subsection (3) shifts the recoverable baseline: recoverable damages may not exceed (a) amounts actually paid by or on behalf of the plaintiff to each provider, (b) amounts that are due and owed to a provider at trial but unpaid, and (c) amounts necessary to pay for future care. This is a statutory limit rather than a presumption of reasonable value, so plaintiffs asserting high billed charges must now explain why unpaid or future-need figures exceed payments or plan obligations.
Limits and specifics of admissible evidence to prove medical damages
Subsection (4) narrows admissible proof to evidence of actual payments or necessary payment obligations. For insured plaintiffs, parties may show the amount the health plan is contractually obligated to pay and the patient's remaining liability; if the claim was not submitted to the plan, the statute permits evidence of what the plan would have paid. It also allows proof of purchase prices when a provider assigns an LOP to a third party, and permits reasonable billed amounts for future care. The provision forces litigants to pivot from arguing over sticker-price charges to producing plan contracts, explanation-of-benefits, and factoring agreements.
Mandatory disclosure when care provided under a letter of protection
When a plaintiff seeks damages for care rendered under a letter of protection, subsection (5) requires disclosure of the LOP itself, itemized and appropriately coded charges, whether the provider sold the receivable and the buyer and sale price if so, the plaintiff's coverage status and plan identity, and whether and who made the referral for the LOP. Those mandated disclosures are focused and transaction-level: they give defense counsel the documents needed to test claims about what was paid or will be paid and to determine whether discounts, write-offs, or third‑party sales change the recoverable amount.
Effective date of the amendments
The bill takes effect May 6, 2026. That fixed effective date matters for pending cases and for transactional practices: parties and providers will need to update intake, billing, and LOP practices before that date to ensure compliance with new discovery and valuation rules.
This bill is one of many.
Codify tracks hundreds of bills on Justice across all five countries.
Explore Justice in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Defendants and their insurers — They gain a statutory ceiling tied to actual payments and plan obligations, reducing exposure to claims based on gross billed charges and simplifying valuation disputes.
- Health plans (public and private) — The statute recognizes plan-allowed amounts and patient liabilities, which can protect plan-negotiated rates from being treated as irrelevant in damage calculations.
- Litigators and courts — The law channels disputes into documentary proof (EOBs, plan contracts, factoring agreements), which may shorten expert battles over 'reasonable value' and make pretrial resolution easier.
Who Bears the Cost
- Plaintiffs and personal injury plaintiffs' counsel — Recoverable damages may shrink when billed charges exceed discounted payments, and counsel must collect and disclose additional transactional documents and factoring details.
- Health care providers that rely on billed charges — Providers who accept discounted payments or sell receivables could see reduced recovery in tort cases because recoverable amounts are tethered to what was paid or the purchase price rather than the full billed amount.
- Factoring companies and buyers of LOP receivables — Buyers become subject to disclosure and scrutiny; the purchase price (often a substantial discount) will be used as evidence and may limit the total collectible amount tied to that receivable.
Key Issues
The Core Tension
The central dilemma is balancing accurate, non-duplicative compensation (preventing plaintiffs from recovering inflated billed charges) against ensuring injured parties receive full compensation for necessary care — a trade-off between preventing windfalls for plaintiffs and avoiding undercompensation when negotiated rates or factoring discounts do not reflect the full social cost of care or the plaintiff's future needs.
The statute resolves one common litigation problem — inflated billed charges — by anchoring damages to actual economic obligations, but that anchoring creates practical and doctrinal challenges. First, it leaves open how to value future medical care: parties must prove 'necessary' future costs, and the bill permits evidence of reasonable billed amounts for future care, but courts will face disputes over forecasting, market rates, and whether to use billed or allowable rates.
Second, the interaction with private-plan contract terms and subrogation or lien rights is unresolved in the text. A plan's contractual obligations and a plan's recovery rights may affect both what is admissible and who ultimately receives payment from a settlement or judgment, creating room for competing claims between plaintiffs, providers, insurers, and lienholders.
Operationally, the disclosure mandate for letters of protection forces new record‑keeping and disclosure practices, but it also invites parties to game timing and submission decisions (for example, whether to submit charges to a plan to establish an 'obligation' or to avoid submission to preserve a larger LOP claim). Requiring disclosure of factoring purchase prices brings market transactions into the courtroom; that will expose the discounts providers accepted and could chill providers' willingness to accept LOPs or sell receivables on typical market terms.
Finally, the statute's silence on how to resolve conflicts among multiple payors, offsets, and lien priorities means practitioners will litigate secondary questions the bill does not answer.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.